Detalles de la búsqueda
1.
An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitors.
Support Care Cancer
; 28(2): 561-570, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31089820
2.
Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer.
Lancet
; 399(10328): 905-907, 2022 03 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35090602
3.
Nilotinib in KIT-driven advanced melanoma: Results from the phase II single-arm NICAM trial.
Cell Rep Med
; 5(3): 101435, 2024 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38417447
4.
REFINE (REduced Frequency ImmuNE checkpoint inhibition in cancers): A multi-arm phase II basket trial testing reduced intensity immunotherapy across different cancers.
Contemp Clin Trials
; 124: 107030, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36519749
5.
Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer.
Cancer Cell
; 41(5): 821-823, 2023 05 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37116490
6.
Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways.
Cancer Discov
; 13(6): 1364-1385, 2023 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36977461
7.
Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer.
Cell Rep Med
; 3(10): 100781, 2022 10 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36240755
8.
Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2.
Nat Med
; 27(8): 1362-1366, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34040262
9.
Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma.
Cancer Cell
; 39(11): 1497-1518.e11, 2021 11 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34715028
10.
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE study.
Nat Cancer
; 2: 1321-1337, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34950880
11.
Functional antibody and T-cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study.
Res Sq
; 2021 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-34580668
12.
Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study.
Nat Cancer
; 2(12): 1321-1337, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35121900
13.
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study.
Nat Cancer
; 2(12): 1305-1320, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35121899
14.
Managing adverse events associated with sorafenib in renal cell carcinoma.
Br J Nurs
; 19(1): 58-60, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20081715
15.
Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer.
Cancer Cell
; 40(4): 438, 2022 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35413273
16.
Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer.
Cancer Cell
; 40(2): 114-116, 2022 02 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34968417
17.
Prognostic markers and tumour growth kinetics in melanoma patients progressing on vemurafenib.
Melanoma Res
; 26(2): 138-44, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26684061
18.
Strategies for assessing and managing the adverse events of sorafenib and other targeted therapies in the treatment of renal cell and hepatocellular carcinoma: recommendations from a European nursing task group.
Eur J Oncol Nurs
; 16(2): 172-84, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21641280
19.
Erythema nodosum-like panniculitis in patients with melanoma treated with vemurafenib.
J Clin Oncol
; 31(19): e320-1, 2013 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23715570
20.
Tumor necrosis factor alpha as a new target for renal cell carcinoma: two sequential phase II trials of infliximab at standard and high dose.
J Clin Oncol
; 25(29): 4542-9, 2007 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-17925549
Resultados
1 -
20
de 20
1
Próxima >
>>